[go: up one dir, main page]

ES2118058T3 - Factor de crecimiento de las celulas t. - Google Patents

Factor de crecimiento de las celulas t.

Info

Publication number
ES2118058T3
ES2118058T3 ES89117317T ES89117317T ES2118058T3 ES 2118058 T3 ES2118058 T3 ES 2118058T3 ES 89117317 T ES89117317 T ES 89117317T ES 89117317 T ES89117317 T ES 89117317T ES 2118058 T3 ES2118058 T3 ES 2118058T3
Authority
ES
Spain
Prior art keywords
growth factor
cells
support
present
cell growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89117317T
Other languages
English (en)
Inventor
Snick Jacques Van
Catherine Uyttenhove
Richard J Simpson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Application granted granted Critical
Publication of ES2118058T3 publication Critical patent/ES2118058T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5425—IL-9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

LA PRESENTE INVENCION ES RELATIVA GENERALMENTE AL FACTOR DE CRECIMIENTO DE CELULAS T. MAS PARTICULARMENTE, LA PRESENTE INVENCION ES RELATIVA AL FACTOR DE CRECIMIENTO DE CELULAS T, LAS CUALES CONTIENEN UNA GLICOPROTEINA LA CUAL SOPORTA "INTERLEUQUIN2" E "INTERLEUQUIN-4" CON INDEPENCIA DEL DESARROLLO DE LA CELULA T DE SOPORTE, ESPECIALMENTE DE FUENTES HUMANAS Y DE RATONES Y ADEMAS LA CUAL ES CAPAZ DE AUMENTAR LA PROLIFERACION DE CELULAS QUE RESPONDEN A IL3- O IL4-. INCLUSO MAS PARTICULARMENTE, LA PRESENTE INVENCION ES RELATIVA AL FACTOR DE CRECIMIENTO DE LA CELULA DE SOPORTE P40, COMPOSICIONES FARMACEUTICAS DE EL, ANTICUERPOS PARA EL Y CLONES MODIFICADOS DE SU DNA. LA PRESENTE INVENCION TAMBIEN CONTEMPLA UN METODO PARA INDUCIR LA PROLIFERACION DE CELULAS DE APOYO T , ASI COMO CELULAS QUE RESPONDEN POR IL3- E IL4-. EL FACTOR DE CRECIMIENTO DE LAS CELULAS T DE APOYO AQUI CONTEMPLADO SE USA ENLA ESTIMULACION DE CELULAS ESPECIFICAS DEL SISTEMA INMUNOLOGICO, SOLO O EN COMBINACION CON IL3 O IL4.
ES89117317T 1988-09-19 1989-09-19 Factor de crecimiento de las celulas t. Expired - Lifetime ES2118058T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/246,482 US5208218A (en) 1988-09-19 1988-09-19 T cell growth factor glycoproteins

Publications (1)

Publication Number Publication Date
ES2118058T3 true ES2118058T3 (es) 1998-09-16

Family

ID=22930867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89117317T Expired - Lifetime ES2118058T3 (es) 1988-09-19 1989-09-19 Factor de crecimiento de las celulas t.

Country Status (12)

Country Link
US (2) US5208218A (es)
EP (1) EP0361284B1 (es)
JP (1) JP3223260B2 (es)
AT (1) ATE167519T1 (es)
AU (1) AU621661B2 (es)
CA (1) CA1341461C (es)
DE (1) DE68928710T2 (es)
DK (1) DK175845B1 (es)
ES (1) ES2118058T3 (es)
IE (1) IE81152B1 (es)
IL (1) IL91691A (es)
PT (1) PT91750B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587302A (en) * 1988-09-19 1996-12-24 Ludwig Institute For Cancer Research T cell growth factor
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5414071A (en) * 1989-05-23 1995-05-09 Genetics Institute, Inc. Human cytokine IL-9
AU635377B2 (en) * 1989-11-21 1993-03-18 University Of Melbourne, The Anti-inflammatory compositions and methods
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
AU5102993A (en) * 1992-09-18 1994-04-12 Merck & Co., Inc. Dna encoding murine precursor interleukin 1beta converting enzyme
TW257792B (es) * 1992-10-01 1995-09-21 Lilly Co Eli
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
AU2007202406B2 (en) * 1995-08-24 2010-08-12 Ligand Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
DK0846173T3 (da) * 1995-08-24 2006-01-16 Genaera Corp Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
US6037149A (en) * 1995-08-24 2000-03-14 Magainin Pharmaceuticals Inc. DNA encoding human asthma associated factor 1
WO1998024904A2 (en) * 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
WO2002100432A1 (en) 2001-06-08 2002-12-19 Genaera Corporation Methods for the modulation of il-13
AU2003226065B2 (en) * 2002-04-12 2009-02-26 Ludwig Institute For Cancer Research, Ltd Recombinant anti-interleukin-9 antibodies
DE602004028007D1 (de) * 2003-05-14 2010-08-19 Bayer Pharmaceuticals Corp Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren
EP2224946B1 (en) * 2007-12-28 2016-11-02 Kalos Therapeutics, Inc. Anti-proliferative compounds and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
CA2033198A1 (en) * 1989-05-24 1990-11-25 Scott D. Lucas Atrial peptide derivatives

Also Published As

Publication number Publication date
AU621661B2 (en) 1992-03-19
IL91691A0 (en) 1990-06-10
EP0361284A3 (en) 1990-09-05
DK458889D0 (da) 1989-09-18
IE892983L (en) 1990-03-19
PT91750A (pt) 1990-03-30
DK175845B1 (da) 2005-03-29
DE68928710D1 (de) 1998-07-23
AU4156389A (en) 1990-03-22
IL91691A (en) 1997-07-13
DK458889A (da) 1990-03-20
ATE167519T1 (de) 1998-07-15
EP0361284A2 (en) 1990-04-04
JP3223260B2 (ja) 2001-10-29
US5208218A (en) 1993-05-04
EP0361284B1 (en) 1998-06-17
CA1341461C (en) 2004-10-26
DE68928710T2 (de) 1999-02-11
PT91750B (pt) 1995-05-31
US5157112A (en) 1992-10-20
IE81152B1 (en) 2000-05-03
JPH034796A (ja) 1991-01-10

Similar Documents

Publication Publication Date Title
ES2118058T3 (es) Factor de crecimiento de las celulas t.
BR9506741A (pt) Aplicação de anticorpos anti-tnf como medicamentos para o tratamento de doenças que apresentam elevados niveis de interleuquin-5 no soro
ES2074042T3 (es) Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores.
ES2007341A6 (es) Un procedimiento para producir m-csf
MX9306220A (es) Ptp 1d: una proteina tirosina fosfatasa novedosa.
IL138424A0 (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
ES2173873T3 (es) Utilizacion de anticuerpos anti-vegf para el tratammiento del cancer.
NL300353I1 (nl) Geneesmiddelen met monoclonale antilichamen, die specifiek zijn voor de menselijk epidermale groeifactorreceptor
ES2196031T3 (es) Derivados peptidicos terapeutico.
BRPI0412138A (pt) anticorpo, hibridoma, método de produzir um anticorpo, composição farmacêutica, métodos de potencializar a atividade de célula, de detectar a presença de células nk e de purificar de uma amostra células nk, e, composição
ES2087061T3 (es) Utilizacion de ribosido o ribotido de aica para la fabricacion de un medicamento contra la crisis cardiaca o el infarto de miocardio en los pacientes que sufren de ateroesclerosis.
ATE153704T1 (de) Anti-t-zell rezeptordeterminanten zur behandlung von autoimmunkrankheiten
ES2085983T3 (es) Antagonistas de anticuerpos de la interleuquina-4 humana.
ES2169023T3 (es) Nueva 1alfa-hidroxi vitaminada d4 y nuevos intermedios y analogos.
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
ES2164914T3 (es) Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar.
ES2067457T3 (es) Celula de origen animal con una proteina antigenica introducida en ella.
BR9811697A (pt) Indução de esterilidade masculina em plantas por expressão de altos nìveis de avidina
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ATE54826T1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2061823T3 (es) Nueva proteina h que es capaz de fijarse a igg, gen que codifica dicha proteina h, y un procedimiento para producir dicha proteina h.
ES2144507T3 (es) Potencializador de la actividad pesticida de bacillus.
ES2166770T3 (es) Anticuerpos monoclonales contra gangliosidos y sus utilizaciones en la inmunoterapia activa especifica de tumores malignos.
ES2070820T3 (es) Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 361284

Country of ref document: ES